Biomedical Advanced Research and Development Authority

Johnson & Johnson's Vaccine Candidate Will Begin Phase 3 of Human Trials

Johnson & Johnson Vaccine Candidate To Begin Phase 3 of Human Trials

Medicine & Technology Sep 24, 2020

Johnson & Johnson will be entering phase three of human trials, including 60,000 participants from three continents. They also continue to look for other possible treatments for coronavirus as their vaccine candidate completes safety and efficacy trials.

Most Popular

How Technology Is Changing the Real Estate Industry?

How a Plant-Based Diet Can Protect Against Breast Cancer: Insights from Nutrition Research

How a Plant-Based Diet Can Protect Against Breast Cancer: Insights from Nutrition Research

Study Reveals High Turnover in Scientific Research Careers: What This Means for Future Scientists

Why It's So Difficult to Lose Weight: The Biological Explanation Behind Obesity

Nikolay Karpenko – Founder of Herculis Group

Nikolay Karpenko Biography, Photo, Career, Accomplishments

Recommended Stories

NASA Shuts Down Voyager 2 Science Instrument After 47 Years to Conserve Power

SPACE

NASA Shuts Down Voyager 2 Science Instrument After 47 Years to Conserve Energy

OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find “Hallucinated” Text in Transcripts

TECH & INNOVATION

OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts

Martian Ice May Support Microbial Life Beneath Its Surface, New Study Suggests

SPACE

Martian Ice May Support Microbial Life Beneath Its Surface, New Study Suggests

NASA Astronaut Hospitalized After Returning from Extended Space Mission

SPACE

NASA Astronaut Hospitalized After Returning from Extended Space Mission